Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
The latest update is out from Daito Pharmaceutical Co., Ltd. ( (JP:4577) ).
Daito Pharmaceutical Co., Ltd. announced the repurchase of 105,200 of its own shares for 220,726,800 yen, conducted through market purchases on the Tokyo Stock Exchange in April 2025. This move is part of a broader strategy approved by the Board of Directors to repurchase up to 300,000 shares, aiming to enhance shareholder value and optimize capital structure.
More about Daito Pharmaceutical Co., Ltd.
Daito Pharmaceutical Co., Ltd. operates in the pharmaceutical industry, focusing on the development and distribution of pharmaceutical products. The company is listed on the Prime Market of the Tokyo Stock Exchange.
YTD Price Performance: -2.39%
Average Trading Volume: 31,975
Technical Sentiment Signal: Buy
Current Market Cap: Yen31.3B
See more insights into 4577 stock on TipRanks’ Stock Analysis page.